Parag Shah
Net worth: 1 383 $ as of 2024-03-30
Profile
Parag Suresh Shah worked as a Director of Pharmaceutical Science at Ikaria, Inc. and later as a Vice President of Business Operations at Bellerophon Therapeutics, Inc. He received an undergraduate degree from Carnegie Mellon University and a doctorate degree from The University of Texas at Austin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-30 | 24,705 ( 0.20% ) | 1 383 $ | 2024-03-30 |
Former positions of Parag Shah
| Companies | Position | End |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Chief Operating Officer | 2023-08-30 |
| IKARIA, INC. | Corporate Officer/Principal | - |
Training of Parag Shah
| Carnegie Mellon University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Stock Market
- Insiders
- Parag Shah
